ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint742,805 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentEpalingesNewBiologix SA
NewBiologix SA Logo
Verified· 2 sources

NewBiologix SA

Summary

About the company

The company's core activity lies in the development and application of technologies for gene and cell therapy, particularly in the areas of Next-Generation Sequencing (NGS), genomic analysis platforms, cell lines, and vector production. The company offers solutions for the development and manufacturing of cell and gene therapies and focuses on providing platforms and services to the biopharmaceutical industry.

AI-generated
Offering

Products & services

Industry:Research & Development
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered6
Xcell™ Genomic Analytical Platform
Next-generation sequencing, bioinformatics, sample preparation and technical support for cell line characterization, rAAV genome sequencing and customer-specific NGS services; uses Illumina, PacBio, Nanopore and Bionano.
Xcell™ Eng-HEK293 Cell Line
Proprietary HEK293 suspension cell line for transient rAAV production; available for licensing for laboratory and production environments, with high rAAV productivity, genomic stability and scalable production.
Xcell™ rAAV Production and Analytics Platform
Platform for production and testing of rAAV candidates; submit sequences, receive rAAV samples and a report, including titer and quality parameters as well as analytical support.
Xcell™ Eng-HEK293 Stable Manufacturing Platform
Stable producer cell lines for rAAV manufacturing; transition from transient to stable production with genomic stability, QA/QC, integration site analysis and scalable commercial manufacturing.
Gene therapy technologies
Technologies for the development and production of rAAV-based gene therapies; stable HEK cell lines with integrated genes for safe, scalable and reproducible vector production.

Knowledge

No knowledge articles yet

Once NewBiologix SA has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

NewBiologix SA in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank NewBiologix SA by reviews, experience and specialisations.

Is this your company?

Claim the company profile of NewBiologix SA to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hier entsteht die Karte
Route de la Corniche 6/8
1066 Epalinges

At a glance

Legal form
Corporation
UID
CHE-291.281.035
Founded
2024 · 2 years
Last commercial register change
February 3, 2026
Employees
11 to 20

Similar companies

AG
Alithea Genomics SA
Epalinges
AT
ALYS Technologies SA
Romanel-Sur-Morges
RL
REGEN LAB SA, succursale industrielle Le Mont-sur-Lausanne
Le Mont-Sur-Lausanne
SB
SEED Biosciences SA
Epalinges